Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19 - 20/11/20
Doi : 10.1016/j.diabet.2020.06.001
G. Targher a, ⁎ 
, A. Mantovani a, C.D. Byrne b, X.-B. Wang c, H.-D. Yan d, Q.-F. Sun e, K.-H. Pan f, K.I. Zheng g, Y.-P. Chen g, h, M. Eslam i, J. George i, M.-H. Zheng g, h, j, ⁎
, A. Mantovani a, C.D. Byrne b, X.-B. Wang c, H.-D. Yan d, Q.-F. Sun e, K.-H. Pan f, K.I. Zheng g, Y.-P. Chen g, h, M. Eslam i, J. George i, M.-H. Zheng g, h, j, ⁎ a Department of Medicine, Section of Endocrinology, Diabetes and Metabolism, University and Azienda Ospedaliera Universitaria Integrata of Verona, Piazzale Stefani 1, 37126 Verona, Italy
b Southampton National Institute for Health Research Biomedical Research Centre, University Hospital Southampton, Southampton General Hospital, Southampton, UK
c Department of Critical Care Medicine, Wenzhou Central Hospital, Wenzhou, China
d Department of Hepatology, Key Laboratory of Diagnosis and Treatment of Digestive System Tumours of Zhejiang Province, Hwamei Hospital, Ningbo No. 2 Hospital, University of Chinese Academy of Sciences, Ningbo, China
e Department of Infectious Diseases, Ruian People's Hospital, Wenzhou, China
f Department of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
g Department of Hepatology, MAFLD Research Centre, the First Affiliated Hospital of Wenzhou Medical University, No. 2, Fuxue Lane, Wenzhou 325000, China
h Institute of Hepatology, Wenzhou Medical University, Wenzhou, China
i Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Sydney, Australia
j Key Laboratory of Diagnosis and Treatment for The Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China
⁎Corresponding author at: Department of Medicine, Section of Endocrinology, Diabetes and Metabolism, University and Azienda Ospedaliera Universitaria Integrata of Verona, Piazzale Stefani 1, 37126 Verona, Italy.Department of Medicine, Section of Endocrinology, Diabetes and Metabolism, University and Azienda Ospedaliera Universitaria Integrata of VeronaPiazzale Stefani 1Verona37126Italy⁎⁎Co-corresponding author at: Department of Hepatology, MAFLD Research Centre, the First Affiliated Hospital of Wenzhou Medical University, No. 2, Fuxue Lane, Wenzhou 325000, China.Department of Hepatology, MAFLD Research Centre, the First Affiliated Hospital of Wenzhou Medical UniversityNo. 2, Fuxue LaneWenzhou 325000China
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Keywords : Coronavirus disease 2019, COVID-19, MAFLD, Metabolic associated fatty liver disease
Abbreviations : COVID-19, MAFLD, NLR, OR, 95% CI
Le texte complet de cet article est disponible en PDF.
Plan
© 2020
Elsevier Masson SAS. Tous droits réservés.
Vol 46 - N° 6
P. 505-507 - novembre 2020 Retour au numéro
Article précédent
- Marked elevation of plasma procalcitonin levels in patients with diabetic ketoacidosis: A possible useful diagnostic biomarker
- T. Anno, R. Shigemoto, F. Kawasaki, S. Irie, N. Miyashita, K. Kaku, H. Kaneto
- Three alternative ways to screen for hyperglycaemia in pregnancy during the COVID-19 pandemic
- A. Vambergue, S. Jacqueminet, M.-F. Lamotte, F. Lamiche-Lorenzini, C. Brunet, P. Deruelle, C. Vayssière, E. Cosson
Bienvenue sur EM-consulte, la référence des professionnels de santé.